The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 4, 2014, Pages 1303-1312

  Martin, Sheree D ^a   McGee, Sean L ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

Inflammation; Insulin resistance; Lipid accumulation; Mitochondrial dysfunction; Reactive oxygen species; Type 2 diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATE; REACTIVE OXYGEN METABOLITE;

ADIPOSE TISSUE; APOPTOSIS; CALCIUM HOMEOSTASIS; DIABETOGENESIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID STORAGE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

INFLAMMATION; INSULIN RESISTANCE; LIPID ACCUMULATION; MITOCHONDRIAL DYSFUNCTION; REACTIVE OXYGEN SPECIES; TYPE 2 DIABETES;

ANIMALS; APOPTOSIS; CALCIUM SIGNALING; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; HUMANS; INSULIN; INSULIN RESISTANCE; MITOCHONDRIA;

EID: 84895555916     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.09.019     Document Type: Review

References (138)

1. P. Zimmet, K.G.M.M. Alberti, and J. Shaw Global and societal implications of the diabetes epidemic Nature 414 2000 782 787
2. G. Danaei, M.M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, C.J. Paciorek, J.K. Lin, F. Farzadfar, Y.H. Khang, G.A. Stevens, M. Rao, M.K. Ali, L.M. Riley, C.A. Robinson, and M. Ezzati National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet 378 2011 31 40
3. G. Roglic, and N. Unwin Mortality attributable to diabetes: estimates for the year 2010 Diabetes Res. Clin. Pract. 87 2010 15 19
4. M. Ezzati, A.B. Friedman, S.C. Kulkarni, and C.J. Murray The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States PLoS Med. 22 2008 e66
5. World Health Organisation Preventing Chronic Diseases, a Vital Investment, WHO Global Report 2005 WHO
6. V.T. Samuel, K.F. Petersen, and G.I. Shulman Lipid-induced insulin resistance: unravelling the mechanism Lancet 375 2010 2267 2277
7. B.H. Goodpaster Mitochondrial deficiency is associated with insulin resistance Diabetes 62 2013 1032 1035
8. J.O. Holloszy "Deficiency" of mitochondria in muscle does not cause insulin resistance Diabetes 62 2013 1036 1040
9. B. Cheatham, and C.R. Kahn Insulin action and the insulin signalling network Endocr. Rev. 16 1995 117 142
10. C.M. Taniguchi, B. Emanuelli, and C.R. Kahn Critical nodes in signalling pathways: insights into insulin action Nat. Rev. Mol. Cell Biol. 7 2006 85 96
11. L. Varela, and T.L. Horvath Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis EMBO Rep. 13 2012 1079 1086
12. Z.R. Zierath, L. He, A. Gumà, E. Odegoard Wahlström, A. Klip, and H. Wallberg-Henriksson Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM Diabetologia 39 1996 1180 1189
13. N.J. Bryant, R. Govers, and D.E. James Regulated transport of the glucose transporter GLUT4 Nat. Rev. Mol. Cell Biol. 3 2002 267 277
14. D. Thiebaud, E. Jacot, R.A. DeFronzo, E. Maeder, E. Jequier, and J.P. Felber The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man Diabetes 31 1982 957 963
15. P.D. Hone, and G. Pacini Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents Diabetes Obes. Metab. 10 2008 699 718
16. M.D. Michael, R.N. Kulkarni, C. Postic, S.F. Previs, G.I. Shulman, M.A. Magnuson, and C.R. Kahn Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction Mol. Cell 6 2000 87 97
17. G. Boden Obesity, insulin resistance and free fatty acids Curr. Opin. Endocrinol. Diabetes Obes. 18 2011 139 143
18. T. Suganami, M. Tanaka, and Y. Ogawa Adipose tissue inflammation and ectopic lipid accumulation Endocr. J. 59 2012 849 857
19. C.H. Mandavia, A.R. Aroor, V.G. Demarco, and J.R. Sowers Molecular and metabolic mechanisms of cardiac dysfunction in diabetes Life Sci. 92 2013 601 608
20. J.S. Marino, Y. Xu, and J.W. Hill Central insulin and leptin-mediated autonomic control of glucose homeostasis Trends Endocrinol. Metab. 22 2011 275 285
21. M. Brownlee Banting Lecture 2004: the pathobiology of diabetic complications - a unifying mechanism Diabetes 54 2005 1615
22. M. Murea, L. Ma, and B.I. Freedman Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications Rev. Diabet. Stud. 9 2012 6 22
23. V.T. Samuel, and G.I. Shulman Mechanisms for insulin resistance: common threads and missing links Cell 148 2012 852 871
24. D.A. Harris, and A.M. Das Control of mitochondrial ATP synthesis in the heart Biochem. J. 280 1991 561 573
25. D.R. Winge Sealing the mitochondrial respirasome Mol. Cell. Biol. 32 2012 2647 2652
26. M.D. Stobbe, S.M. Houten, A.H. van Kampen, R.J. Wanders, and P.D. Moerland Improving the description of metabolic networks: the TCA cycle as example FASEB J. 26 2012 3625 3636
27. S. Papa, P.L. Martino, G. Capitanio, A. Gaballo, D. De Rasmo, A. Signorile, and V. Petruzzella The oxidative phosphorylation system in mammalian mitochondria Adv. Exp. Med. Biol. 942 2012 3 37
28. M.D. Brand, and D.G. Nicholls Assessing mitochondrial dysfunction in cells Biochem. J. 435 2011 297 312
29. D.F. Rolfe, and M.D. Brand Contribution of mitochondrial proton leak to skeletal muscle respiration and to standard metabolic rate Am. J. Physiol. Cell Physiol. 271 1996 C1380 C1389
30. A. Boveris, J.J. Poderoso, M.C. Carreras, and E. Cadenas Regulation of mitochondrial respiration by oxygen and nitric oxide Ann. N. Y. Acad. Sci. 899 2000 121 135
31. S. Dröse, and U. Brandt Molecular mechanisms of superoxide production by the mitochondrial respiratory chain Adv. Exp. Med. Biol. 748 2012 145 169
32. L. Galluzzi, O. Kepp, and G. Kroemer Mitochondria: master regulators of danger signalling Nat. Rev. Mol. Cell Biol. 13 2012 780 788
33. J.C. Rathmell, and C.B. Thompson Pathways of apoptosis in lymphocyte development, homeostasis and disease Cell 109 2002 S97 S107
34. J.C. Reed Mechanisms of apoptosis Am. J. Pathol. 157 2000 1415 1430
35. D. Wallach, T.B. Kang, and A. Kovalenko The extrinsic cell death pathway and the élan mortel Cell Death Differ. 15 2008 1533 1541
36. M.P. Murphy How mitochondria produce reactive oxygen species Biochem. J. 417 2009 1 13
37. C. Lee, K. Yen, and P. Cohen Humanin: a harbinger of mitochondrial derived peptides? Trends Endocrinol. Metab. 24 2013 222 228
38. I. Drago, P. Pizzo, and T. Pozzan After half a century mitochondrial calcium in- and efflux machineries reveal themselves EMBO J. 30 2011 4119 4125
39. 2 + Cell Calcium 52 2012 28 35
40. B. Glancy, and R.S. Balaban Protein composition and function of red and white skeletal muscle mitochondria Am. J. Physiol. Cell Physiol. 300 2011 C1280 C1290
41. 2 + influx mechanisms Sci. China Life Sci. 54 2011 763 769
42. 2 + uptake that regulates cell survival Cell 151 2012 630 644
43. 2 + exchange Proc. Natl. Acad. Sci. U. S. A. 107 2010 436 441
44. 2 + exchanger Cell Calcium 52 2012 9 15
45. P. Bernardi, and S. von Stockum The permeability transition pore as a Ca(2 +) release channel: new answers to an old question Cell Calcium 52 2012 22 27
46. A. Rasola, and P. Bernardi Mitochondrial permeability transition in Ca(2 +)-dependent apoptosis and necrosis Cell Calcium 50 2011 222 233
47. W. Reardon, R.J. Ross, M.G. Sweeney, L.M. Luxon, M.E. Pembrey, A.E. Harding, and R.C. Trembath Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA Lancet 340 1992 1376 1379
48. T. Kadowaki, H. Kadowaki, Y. Mori, K. Tobe, R. Sakuta, Y. Suzuki, Y. Tanabe, H. Sakura, T. Awata, and Y. Goto A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA N. Engl. J. Med. 330 1994 962 968
49. R. Becker, H. Laube, T. Linn, and M.S. Damian Insulin resistance in patients with the mitochondrial tRNA(Leu(UUR)) gene mutation at position 3243 Exp. Clin. Endocrinol. Diabetes 110 2002 291 297
50. D.E. Kelley, M. Mokan, J.A. Simoneau, and L.J. Mandarino Interaction between glucose and free fatty acid metabolism in human skeletal muscle J. Clin. Invest. 92 1993 91 98
51. D.E. Kelley, and J.A. Simoneau Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus J. Clin. Invest. 94 1994 2349 2356
52. J.A. Simoneau, and D.E. Kelley Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM J. Appl. Physiol. 83 1997 166 171
53. D.E. Kelley, J. He, E.V. Menshikova, and V.B. Ritov Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes Diabetes 51 2002 2944 2950
54. R. Boushel, E. Gnaiger, P. Schjerling, M. Skovbro, R. Kraunsøe, and F. Dela Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle Diabetologia 50 2007 790 796
55. V.B. Ritov, E.V. Menshikova, J. He, R.E. Ferrell, B.H. Goodpaster, and D.E. Kelley Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes Diabetes 54 2005 8 14
56. M. Mogensen, K. Sahlin, M. Fernström, D. Glintborg, B.F. Vind, H. Beck-Nielsen, and K. Højlund Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes Diabetes 56 2007 1592 1599
57. E. Phielix, V.B. Schrauwen-Hinderling, M. Mensink, E. Lenaers, R. Meex, J. Hoeks, M.E. Kooi, E. Moonen-Kornips, J.P. Sels, M.K. Hesselink, and P. Schrauwen Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients Diabetes 57 2008 2943 2949
58. X. Huang, K.F. Eriksson, A. Vaag, M. Lehtovirta, M. Hansson, E. Laurila, T. Kanninen, B.T. Olesen, I. Kurucz, L. Koranyi, and L. Groop Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle Diabetes 48 1999 1508 1514
59. L. Mustelin, K.H. Pietiläinen, A. Rissanen, A.R. Sovijärvi, P. Piirilä, J. Naukkarinen, L. Peltonen, J. Kaprio, and H. Yki-Järvinen Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity Am. J. Physiol. Endocrinol. Metab. 295 2008 E148 E154
60. T. Rönn, P. Poulsen, T. Tuomi, B. Isomaa, L. Groop, A. Vaag, and C. Ling Genetic variation in ATP5O is associated with skeletal muscle ATP50 mRNA expression and glucose uptake in young twins PLoS One 4 2009 e4793
61. V. Rimbert, Y. Boirie, M. Bedu, J.F. Hocquette, P. Ritz, and B. Morio Muscle fat oxidative capacity is not impaired by age but by physical inactivity: association with insulin sensitivity FASEB J. 18 2004 737 739
62. F.H. van Tienen, S.F. Praet, H.M. de Feyter, N.M. van den Broek, P.J. Lindsey, K.G. Schoonderwoerd, I.F. de Coo, K. Nicolay, J.J. Prompers, H.J. Smeets, and L.J. van Loon Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes J. Clin. Endocrinol. Metab. 97 2012 3261 3269
63. K.F. Petersen, S. Dufour, D. Befroy, R. Garcia, and G.I. Shulman Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes N. Engl. J. Med. 350 2004 664 671
64. M.E. Patti, A.J. Butte, S. Crunkhorn, K. Cusi, R. Berria, S. Kashyap, Y. Miyazaki, I. Kohane, M. Costello, R. Saccone, E.J. Landaker, A.B. Goldfine, E. Mun, R. DeFronzo, J. Finlayson, C.R. Kahn, and L.J. Mandarino Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1 Proc. Natl. Acad. Sci. U. S. A. 100 2003 8466 8471
65. V.K. Mootha, C.M. Lindgren, K.F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P. Puigserver, E. Carlsson, M. Ridderstråle, E. Laurila, N. Houstis, M.J. Daly, N. Patterson, J.P. Mesirov, T.R. Golub, P. Tamayo, B. Spiegelman, E.S. Lander, J.N. Hirschhorn, D. Altshuler, and L.C. Groop PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes Nat. Genet. 34 2003 267 273
66. K. Baar, A.R. Wende, T.E. Jones, M. Marison, L.A. Nolte, M. Chen, D.P. Kelly, and J.O. Holloszy Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1 FASEB J. 14 2002 1879 1886
67. K. Morino, K.F. Petersen, and G.I. Shulman Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction Diabetes 55 2006 S9 S15
68. H.K. Karlsson, M. Ahlsén, J.R. Zierath, H. Wallberg-Henriksson, and H.A. Koistinen Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients Diabetes 55 2006 1283 1288
69. C.S. Choi, D.E. Befroy, R. Codella, S. Kim, R.M. Reznick, Y.J. Hwang, Z.X. Liu, H.Y. Lee, A. Distefano, V.T. Samuel, D. Zhang, G.W. Cline, C. Handschin, J. Lin, K.F. Petersen, B.M. Spiegelman, and G.I. Shulman Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism Proc. Natl. Acad. Sci. U. S. A. 105 2008 19926 19931
70. K.F. Petersen, D. Befroy, S. Dufour, J. Dziura, C. Ariyan, D.L. Rothman, L. DiPietro, G.W. Cline, and G.I. Shulman Mitochondrial dysfunction in the elderly: possible role in insulin resistance Science 300 2003 1140 1142
71. P. Chomentowski, P.M. Coen, Z. Radikova, B.H. Goodpaster, and F.G. Toledo Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility J. Clin. Endocrinol. Metab. 96 2011 494 503
72. R. Fabris, G. Mingrone, G. Milan, M. Manco, M. Granzotto, A.D. Pozza, A. Scarda, R. Serra, A.V. Greco, G. Federspil, and R. Vettor Further lowering of muscle lipid oxidative capacity in obese subjects after bilopancreatic diversion J. Clin. Endocrinol. Metab. 89 2004 1753 1759
73. J.R. Berggren, K.E. Boyle, W.H. Chapman, and J.A. Houmard Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise Am. J. Physiol. Endocrinol. Metab. 294 2008 E726 E732
74. F.G. Toledo, E.V. Menshikova, K. Azuma, Z. Radikova, C.A. Kelley, V.B. Ritov, and D.E. Kelley Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content Diabetes 57 2008 987 994
75. C. Bonnard, A. Durand, S. Peyrol, E. Chanseaume, M.A. Chauvin, B. Morio, H. Vidal, and J. Rieusset Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice J. Clin. Invest. 118 2008 789 800
76. N. Turner, C.R. Bruce, S.M. Beale, K.L. Hoehn, T. So, M.S. Rolph, and G.J. Cooney Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents Diabetes 56 2007 2085 2092
77. J.A. Simoneau, J.H. Veerkamp, L.P. Turcotte, and D.E. Kelley Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss FASEB J. 13 1999 2051 2060
78. J.A. Pospisilik, C. Knauf, N. Joza, P. Benit, M. Orthofer, P.D. Cani, I. Ebersberger, T. Nakashima, R. Sarao, G. Neely, H. Esterbauer, A. Kozlov, C.R. Kahn, G. Kroemer, P. Rustin, R. Burcelin, and J.M. Penninger Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes Cell 2007 131 2007 476 491
79. R. Quintens, S. Singh, K. Lemaire, K. De Bock, M. Granvik, A. Schraenen, I.O. Vroegrijk, V. Costa, P. Van Noten, D. Lambrechts, S. Lehnert, L. Van Lommel, L. Thorrez, G. De Faudeur, J.A. Romijn, J.M. Shelton, L. Scorrano, H.R. Lijnen, P.J. Voshol, P. Carmeliet, P.P. Mammen, and F. Schuit Mice deficient in the respiratory chain gene Cox6a2 are protected against high-fat diet-induced obesity and insulin resistance PLoS One 8 2013 e56719
80. D.H. Han, C.R. Hancock, S.R. Jung, K. Higashida, S.H. Kim, and J.O. Holloszy Deficiency of the mitochondrial electron transport chain in muscle does not cause insulin resistance PLoS One 12 2011 e19739
81. A. Wredenberg, C. Freyer, M.E. Sandström, A. Katz, R. Wibom, H. Westerblad, and N.G. Larsson Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance Biochem. Biophys. Res. Commun. 350 2006 202 207
82. C. Zechner, L. Lai, J.F. Zechner, T. Geng, Z. Yan, J.W. Rumsey, D. Collia, Z. Chen, D.F. Wozniak, T.C. Leone, and D.P. Kelly Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity Cell Metab. 12 2010 633 642
83. S.R. Preis, J.M. Massaro, S.J. Robins, U. Hoffmann, R.S. Vasan, T. Irlbeck, J.B. Meigs, P. Sutherland, R.B. D'Agostino Sr., C.J. O'Donnell, and C.S. Fox Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study Obesity 18 2010 2191 2198
84. P. Mitrou, E. Boutati, V. Lambadiari, E. Maratou, A. Papakonstantinou, V. Komesidou, L. Sidossis, N. Tountas, N. Katsilambros, T. Economopoulos, S.A. Raptis, and G. Dimitriadis Rates of glucose uptake in adipose tissue and muscle in vivo after a mixed meal in women with morbid obesity J. Clin. Endocrinol. Metab. 94 2009 2958 2961
85. L. Wilson-Fritch, S. Nicoloro, M. Chouinard, M.A. Lazar, P.C. Chui, J. Leszyk, J. Straubhaar, M.P. Czech, and S. Corvera Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone J. Clin. Invest. 114 2004 1281 1289
86. H.J. Choo, J.H. Kim, O.B. Kwon, C.S. Lee, J.Y. Mun, S.S. Han, Y.S. Yoon, G. Yoon, K.M. Choi, and Y.G. Ko Mitochondria are impaired in the adipocytes of type 2 diabetic mice Diabetologia 49 2006 784 791
87. J.X. Rong, Y. Qiu, M.K. Hansen, L. Zhu, V. Zhang, M. Xie, Y. Okamoto, M.D. Mattie, H. Higashiyama, S. Asano, J.C. Strum, and T.E. Ryan Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone Diabetes 56 2007 1751 1760
88. I. Bogacka, H. Xie, G.A. Bray, and S.R. Smith Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo Diabetes 54 2005 1392 1399
89. M.J. Laye, R.S. Rector, S.O. Warner, S.P. Naples, A.L. Perretta, G.M. Uptergrove, M.H. Laughlin, J.P. Thyfault, F.W. Booth, and J.A. Ibdah Changes in visceral adipose tissue mitochondrial content with type 2 diabetes and daily voluntary wheel running in OLETF rats J. Physiol. 587 2009 3729 3739
90. L.N. Sutherland, L.C. Capozzi, N.J. Turchinsky, R.C. Bell, and D.C. Wright Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance Am. J. Physiol. Endocrinol. Metab. 295 2008 E1076 E1083
91. J. Szendroedi, M. Chmelik, A.I. Schmid, P. Nowotny, A. Brehm, M. Krssak, E. Moser, and M. Roden Abnormal hepatic energy homeostasis in type 2 diabetes Hepatology 50 2009 1079 1086
92. A.I. Schmid, J. Szendroedi, M. Chmelik, M. Krssák, E. Moser, and M. Roden Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes Diabetes Care 34 2011 448 453
93. S. Bouderba, M.N. Sanz, C. Sánchez-Martín, M.Y. El-Mir, G.R. Villanueva, D. Detaille, and E.A. Koceïr Hepatic mitochondrial alterations and increased oxidative stress in nutritional diabetes-prone Psammomys obesus model Exp. Diabetes Res. 2012 2012 430176
94. T.H. Kuo, K.H. Moore, F. Giacomelli, and J. Wiener Defective oxidative metabolism of heart mitochondria from genetically diabetic mice Diabetes 32 1983 781 787
95. T.H. Kuo, F. Giacomelli, J. Wiener, and K. Lapanowski-Netzel Pyruvate dehydrogenase activity in cardiac mitochondria from genetically diabetic mice Diabetes 34 1995 1075 1081
96. S. Boudina, S. Sena, B.T. O'Neill, P. Tathireddy, M.E. Young, and E.D. Abel Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity Circulation 112 2005 2686 2695
97. J. Buchanan, P.K. Mazumder, P. Hu, G. Chakrabarti, M.W. Roberts, U.J. Yun, R.C. Cooksey, S.E. Litwin, and E.D. Abel Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity Endocrinology 146 2005 5341 5349
98. O.J. How, E. Aasum, D.L. Severson, W.Y. Chan, M.F. Essop, and T.S. Larsen Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice Diabetes 55 2006 466 473
99. S. Boudina, S. Sena, H. Theobald, X. Sheng, J.J. Wright, X.X. Hu, S. Aziz, J.J. Johnson, H. Bugger, V.G. Zaha, and E.D. Abel Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling protein Diabetes 32 2007 781 787
100. S. Boudina, H. Bugger, S. Sena, B.T. O'Neill, V.G. Zaha, O. Ilkun, J.J. Wright, P.K. Mazumder, E. Palfreyman, T.J. Tidwell, H. Theobald, O. Khalimonchuk, B. Wayment, X. Sheng, K.J. Rodnick, R. Centini, D. Chen, S.E. Litwin, B.E. Weimer, and E.D. Abel Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart Circulation 119 2009 1272 1283
101. G. Ye, N.S. Metreveli, J. Ren, and P.N. Epstein Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production Diabetes 52 2003 777 783
102. S. Gray, and J.K. Kim New insights into insulin resistance in the diabetic heart Trends Endocrinol. Metab. 22 2011 394 403
103. B.B. Lowell, and G.I. Shulman Mitochondrial dysfunction and type 2 diabetes Science 307 2005 384 387
104. K. Morino, K.F. Petersen, S. Dufour, D. Befroy, J. Frattini, N. Shatzkes, S. Neschen, M.F. White, S. Bilz, S. Sono, M. Pypaert, and G.I. Shulman Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents J. Clin. Invest. 115 2005 3587 3593
105. C.R. Bruce, A.J. Hoy, N. Turner, M.J. Watt, T.L. Allen, K. Carpenter, G.J. Cooney, M.A. Febbraio, and E.W. Kraegen Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance Diabetes 58 2009 550 558
106. E. Gnaiger Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology Int. J. Biochem. Cell Biol. 41 2009 1837 1845
107. T.R. Koves, J.R. Ussher, R.C. Noland, D. Slentz, M. Mosedale, O. Ilkayeva, J. Bain, R. Stevens, J.R. Dyck, C.B. Newgard, G.D. Lopaschuk, and D.M. Muoio Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance Cell Metab. 7 2008 45 56
108. K.L. Hoehn, C. Hohnen-Behrens, A. Cederberg, L.E. Wu, N. Turner, T. Yuasa, Y. Ebina, and D.E. James IRS1-independent defects define major nodes of insulin resistance Cell Metab. 7 2008 421 433
109. N. Houstis, E.D. Rosen, and E.S. Lander Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 440 2006 944 948
110. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans J. Clin. Invest. 119 2009 573 581
111. K.H. Fisher-Wellman, and P.D. Neufer Linking mitochondrial bioenergetics to insulin resistance via redox biology Trends Endocrinol. Metab. 23 2012 142 153
112. S. Paglialunga, B. van Bree, M. Bosma, M.P. Valdecantos, E. Amengual-Cladera, J.A. Jörgensen, D. van Beurden, G.J. den Hartog, D.M. Ouwens, J.J. Briedé, P. Schrauwen, and J. Hoeks Targeting of mitochondrial reactive oxygen species production does not avert lipid-induced insulin resistance in muscle tissue from mice Diabetologia 55 2012 2759 2768
113. K.L. Hoehn, A.B. Salmon, C. Hohnen-Behrens, N. Turner, A.J. Hoy, G.J. Maghzal, R. Stocker, H. Van Remmen, E.W. Kraegen, G.J. Cooney, A.R. Richardson, and D.E. James Insulin resistance is a cellular antioxidant defense mechanism Proc. Natl. Acad. Sci. U. S. A. 106 2009 17787 17792
114. Q. Li, N.Y. Spencer, F.D. Oakley, G.R. Buettner, and J.F. Engelhardt Endosomal Nox2 facilitates redox-dependent induction of NF-kappaB by TNF-alpha Antioxid. Redox Signal. 11 2009 1249 1263
115. M.J. Morgan, and Z.G. Liu Reactive oxygen species in TNFα-induced signalling and cell death Mol. Cells 30 2010 1 12
116. M.E. Tome, K. Lee, M.C. Jaramillo, and M.M. Briehl Mitochondria are the primary source of the H(2)O(2) signal for glucocorticoid-induced apoptosis of lymphoma cells Exp. Ther. Med. 4 2 Feb 2012 237 242
117. K. Loh, H. Deng, A. Fukushima, X. Cai, B. Boivin, S. Galic, C.R. Bruce, B.J. Shields, B. Skiba, L.M. Ooms, N. Stepto, B. Wu, C.A. Mitchell, N.K. Tonks, M.J. Watt, M.A. Febbraio, P.J. Crack, S. Andrikopoulos, and T. Tiganis Reactive oxygen species enhance insulin sensitivity Cell Metab. 10 2009 260 272
118. T.R. Hurd, Y. Collins, I. Abakumova, E.T. Chouchani, B. Baranowski, I.M. Fearnley, T.A. Prime, M.P. Murphy, and A.M. James Inactivation of pyruvate dehydrogenase kinase 2 by mitochondrial reactive oxygen species J. Biol. Chem. 287 2012 35153 35160
119. A.M. James, Y. Collins, A. Logan, and M.P. Murphy Mitochondrial oxidative stress and the metabolic syndrome Trends Endocrinol. Metab. 23 2012 429 434
120. A.M. Johnson, and J.M. Olefsky The origins and drivers of insulin resistance Cell 152 2013 673 684
121. N. Turner, G.M. Kowalski, S.J. Leslie, S. Risis, C. Yang, R.S. Lee-Young, J.R. Babb, P.J. Meikle, G.I. Lancaster, D.C. Henstridge, P.J. White, E.W. Kraegen, A. Marette, G.J. Cooney, M.A. Febbraio, and C.R. Bruce Diabetologia 56 2013 1638 1648
122. R. Zhou, A.S. Yazdi, P. Menu, and J. Tschopp A role for mitochondria in NLRP3 inflammasome activation Nature 469 2011 221 225
123. T. Lane, B. Flam, R. Lockey, and N. Kolliputi TXNIP shuttling: the missing link bet6ween oxidative stress and inflammasome activation Front. Physiol. 4 2013 50
124. S.N. Vallerie, and G.S. Hotamisligil The role of JNK proteins in metabolism Sci. Transl. Med. 2 2010 60vr5
125. K. Shimada, T.R. Crother, J. Karlin, J. Dagvadorj, N. Chiba, S. Chen, V.K. Ramanujan, A.J. Wolf, L. Vergnes, D.M. Ojcius, A. Rentsendorj, M. Vargas, C. Guerrero, Y. Wang, K.A. Fitzgerald, D.M. Underhill, T. Town, and M. Arditi Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis Immunity 36 2012 401 414
126. B. Vandanmagsar, Y.H. Youm, A. Ravussin, J.E. Galgani, K. Stadler, R.L. Mynatt, E. Ravussin, J.M. Stephens, and V.D. Dixit The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance Nat. Med. 17 2011 179 188
127. J. Yu, S.A. Novgorodov, D. Chudakova, H. Zhu, A. Bielawska, J. Bielawski, L.M. Obeid, M.S. Kindy, and T.I. Gudz JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction J. Biol. Chem. 282 2007 25940 25949
128. M.R. Owen, E. Doran, and A.P. Halestrap Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem. J. 348 2000 607 614
129. B. Brunmair, K. Staniek, F. Gras, N. Schaf, A. Althaym, R. Clara, M. Roden, E. Gnaiger, H. Nohl, W. Waldhausl, and C. Furnsinn Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their anti-diabetic actions? Diabetes 53 2004 1052 1059
130. N. Papanas, and E. Maltezos Metformin: a review of its use in the treatment of type 2 diabetes Clin. Med. Ther. 1 2009 1367 1381
131. R.S. Hundal, M. Krssak, S. Dufour, D. Laurent, V. Lebon, V. Chandramouli, S.E. Inzucchi, W.C. Schumann, K.T. Petersen, B.R. Landau, and G.I. Shulman Mechanism by which metformin reduces glucose production in type 2 diabetes Diabetes 49 2000 2063 2069
132. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 2001 1167 1174
133. A. Hubert, A. Husson, A. Chédeville, and A. Lavoinne AMP-activated protein kinase counteracted the inhibitory effect of glucose on the phosphoenolpyruvate carboxykinase gene expression in rat hepatocytes FEBS Lett. 481 2000 209 212
134. M. Foretz, S. Hébrard, J. Leclerc, E. Zarrinpashneh, M. Soty, G. Mithieux, K. Sakamoto, F. Andreelli, and B. Viollet Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state J. Clin. Invest. 120 2010 2355 2369
135. R.A. Miller, Q. Chu, J. Xie, M. Foretz, B. Viollet, and M.J. Birnbaum Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP Nature 494 2013 256 260
136. M.F. Yip, G. Ramm, M. Larance, K.L. Hoehn, M.C. Wagner, M. Gilhaus, and D.E. James CaMKII-mediated phosphorylation of the myosin motor Myo1c is required for insulin-stimulated GLUT4 translocation in adipocytes Cell Metab. 8 2008 384 398
137. J. Rieusset, J. Fauconnier, M. Paillard, E. Belaidi, E. Tubbs, M.A. Chauvin, A. Durand, A. Bravard, G. Teixeira, B. Bartosch, M. Michelet, P. Theurey, G. Vial, M. Demion, E. Blond, F. Zoulim, L. Gomez, H. Vidal, A. Lacampagne, and M. Ovize Disruption of cyclophilin D-mediated calcium transfer from the ER to mitochondria contributes to hepatic ER stress and insulin resistance Hepatology 2012 10.1002/hep.26189
138. N. Joza, J.A. Pospisilik, E. Hangen, T. Hanada, N. Modjtahedi, J.M. Penninger, and G. Kroemer AIF: not just an apoptosis inducing factor Ann. N. Y. Acad. Sci. 1171 2009 2 11